SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?

Detalles Bibliográficos
Autores principales: Kuster, Gabriela M, Pfister, Otmar, Burkard, Thilo, Zhou, Qian, Twerenbold, Raphael, Haaf, Philip, Widmer, Andreas F, Osswald, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Viewpoints
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184407/
https://www.ncbi.nlm.nih.gov/pubmed/32196087
http://dx.doi.org/10.1093/eurheartj/ehaa235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184407/
https://www.ncbi.nlm.nih.gov/pubmed/32196087
http://dx.doi.org/10.1093/eurheartj/ehaa235

Ejemplares similares